Hazlett, Burt & Watson’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-183
Closed -$2K – 923
2026
Q2
$2K Sell
183
-5
-3% -$60 ﹤0.01% 850
2026
Q1
$1K Hold
188
– – ﹤0.01% 892
2025
Q4
$1K Buy
188
+1
+0.5% +$8 ﹤0.01% 901
2025
Q3
$2K Hold
187
– – ﹤0.01% 815
2025
Q2
$2K Sell
187
-5
-3% -$52 ﹤0.01% 730
2025
Q1
$3K Sell
192
-24
-11% -$369 ﹤0.01% 701
2024
Q4
$3K Buy
216
+3
+1% +$49 ﹤0.01% 672
2024
Q3
$4K Sell
213
-6
-3% -$124 ﹤0.01% 626
2024
Q2
$5K Sell
219
-34
-13% -$676 ﹤0.01% 593
2024
Q1
$4K Buy
253
+2
+0.8% +$34 ﹤0.01% 603
2023
Q4
$3K Sell
251
-121
-33% -$1.65K ﹤0.01% 600
2023
Q3
$6K Buy
372
+3
+0.8% +$63 ﹤0.01% 549
2023
Q2
$6K Buy
369
+11
+3% +$239 ﹤0.01% 537
2023
Q1
$8K Sell
358
-50
-12% -$1.34K 0.01% 473
2022
Q4
$10K Buy
408
+32
+9% +$818 0.01% 457
2022
Q3
$9K Buy
376
+43
+13% +$1.3K 0.01% 465
2022
Q2
$11K Hold
333
– – 0.01% 448
2022
Q1
$11K Buy
+333
New +$11.4K 0.01% 462

Other funds holding OGN

Hazlett, Burt & Watson's OGN Position: Q3 2026 in Review

Hazlett, Burt & Watson sold out of Organon & Co (OGN) in Q3 2026, closing a stake of 183 shares — an estimated $2K sold.

Hazlett, Burt & Watson first reported a position in OGN in Q1 2022 and held it in 18 quarters. The position peaked at $11K in Q2 2022. 264 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Hazlett, Burt & Watson reported no remaining Organon & Co position as of Q3 2026 after selling out during the quarter.
  • Hazlett, Burt & Watson sold 183 Organon & Co shares in Q3 2026, an estimated $2K.
  • Hazlett, Burt & Watson first reported a position in Organon & Co in Q1 2022 and held it in 18 quarters.
  • Hazlett, Burt & Watson's Organon & Co position peaked at $11K in Q2 2022.
  • 264 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q3 2026, filed 4 Nov 2026.